The 2026 European Association of Urology (EAU) annual meeting featured an advancement in metastatic castration resistant ...
(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured an advancement in metastatic castration resistant prostate cancer (mCRPC) therapy session and a presentation by Dr ...
Background Although the increased risk of cardiovascular disease in patients with SLE is well-documented, effective tools for risk stratification remain elusive. This study sought to explore the ...
Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...
The Citizens Life Sciences Conference 2026 March 11, 2026 9:35 AM EDTCompany ParticipantsAndrew Peters - Senior Vice President ...
Scleral buckle repair for rhegmatogenous retinal detachment yields favorable visual outcomes in young adults, a study shows.
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing ...
Durable 76% complete response (CR) rate at 12 months with 95% CR rate at any time in high-risk NMIBCBCG-unresponsive patients achieved an 80% CR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results